January 13, 2026 — INCATE (INCubator for Antibacterial Therapies in Europe), the antimicrobial incubator supporting the advancement of early stage anti-infectives, announced today a partnership with Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical [...]
More news
Photo credits: INCATE Cavenagh Health exists to foster innovation and support the creation of new [...]
Antimicrobial resistance (AMR) is a global growing threat. Only through closer collaboration across all [...]
September 19th, 2024 – INCATE, the INCubator for Antibacterial Therapies in Europe, is glad to [...]
September 10th, 2024 – INCATE, the INCubator for Antibacterial Therapies in Europe, is pleased [...]
September 2nd, 2024 - INCATE (the INCubator for Antibacterial Therapies in Europe) is celebrating its [...]
The INCATE Selection Committee selected the new 6 ventures for Stage I support. Meet [...]
The 10th edition of the AMR World Congress, set to take place on September 5th-6th [...]
August 12th, 2024 - INCATE, the INCubator for Antibacterial Therapies in Europe, is pleased [...]
